Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
03/2010
03/17/2010EP2162455A2 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments
03/17/2010EP2162153A1 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
03/17/2010EP2162132A1 Heterocyclic kinase modulators
03/17/2010EP2162129A1 Use of hdac inhibitors for the treatment of bone destruction
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010EP1303536B1 Novel fibroblast growth factor (fgf23) and methods for use
03/17/2010CN101674839A Process for producing osteocalcin-containing extract
03/17/2010CN101674817A Novel use of hydroxytyrosol
03/17/2010CN101671393A Angiopoietin-2 specific binding agents
03/17/2010CN101671315A New crystal form of febuxostat and preparation method thereof
03/17/2010CN101671260A Method for preparing O-desmethyl-venlafaxine
03/17/2010CN101670119A polynucleotide
03/17/2010CN101670078A External medicament cervical ointment for treating cervical osteoarthritis
03/17/2010CN101670072A Paste for dissolving stasis and relieving pain
03/17/2010CN101670068A Medicament for treating gonarthromeningitis and preparation technology thereof
03/17/2010CN101670058A Traditional Chinese medicine composition for treating gout
03/17/2010CN101670039A Traditional Chinese medicine for curing lupus erythematosis and preparation method thereof
03/17/2010CN101670033A Ointment for curing protrusion of lumbar vertebral disc, sciatica, pain of neck, shoulder and legs, rheumatoid arthritis and hyperosteogeny
03/17/2010CN101670024A Osteonecrosis rehabilitation capsule
03/17/2010CN101670016A Traditional Chinese medicine composition for treating osteoarthrosis
03/17/2010CN101670011A Medicament for treating rheumatism and rheumatoid and preparation method thereof
03/17/2010CN101670010A Method for extracting flavonoid glycoside substance
03/17/2010CN101669991A Gendarussa wine and manufacturing method and application thereof
03/17/2010CN101669988A Extraction process of clerodendranthus spicatus
03/17/2010CN101669946A Pharmaceutical purpose of compound comprising ferulic acid and matrine alkaloid on prevention and treatment of osteoarthropathy
03/17/2010CN101669936A Drug combination containing pratensein and application thereof in drugs
03/17/2010CN101669935A Drug combination containing prunetin and application thereof in drugs
03/17/2010CN101669886A Self-repairing moisture mask
03/17/2010CN100594033C Chinese traditional medicine compound took orally for treating cervical spondylotic radiculopathy
03/17/2010CN100594029C Medicinal composition for injections in articular cavity
03/17/2010CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof
03/16/2010US7678887 Identification and cloning of a novel human gene, RET16, involved in the intracellular signaling cascade
03/16/2010US7678885 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
03/16/2010US7678884 Biologically active peptide and agent containing the same
03/16/2010CA2459981C For producing biologically active products
03/16/2010CA2438646C Pyrimidine derivatives for inhibition of cell-proliferation
03/16/2010CA2437718C Carboline derivatives
03/16/2010CA2396965C Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
03/16/2010CA2395121C Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method
03/16/2010CA2372575C Bradykinin receptor antagonists
03/11/2010WO2010028254A2 Substituted quinazoline inhibitors of growth factor receptor tyrosine kinases
03/11/2010WO2010028190A2 Compounds, compositions and methods of using same for modulating uric acid levels
03/11/2010WO2010027875A2 Compounds that modulate intracellular calcium
03/11/2010WO2010027500A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010WO2010027114A1 Use of pyrazole-pyridine derivatives and its salts for treating or reventin osteoporosis
03/11/2010WO2010027014A1 Method for improving absorption of s-adenosyl-l-methionine, and composition having improved s-adenosyl-l-methionine absorption
03/11/2010WO2010027005A1 Substituted amine derivative and medicinal composition comprising same as the active ingredient
03/11/2010WO2010027002A1 Ring-fused morpholine derivative having pi3k-inhibiting activity
03/11/2010WO2010026766A1 Agent for treating myelofibrosis
03/11/2010WO2010026701A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient
03/11/2010WO2010004512A3 Dicarba-analgues of octreotide
03/11/2010WO2009154810A3 Delivery systems for multiple active agents
03/11/2010WO2009129433A4 Alpha adrenergic receptor agonists for treatment of degenerative disc disease
03/11/2010US20100063120 Imidazolidine Derivatives, Uses Therefor, Preparation Thereof and Compositions Comprising Such
03/11/2010US20100063105 Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
03/11/2010US20100063098 Pyridone derivatives as p38a mapk inhibitors
03/11/2010US20100063079 Pyrimidyl Sulphone Amide Derivatives as Chemokine Receptor Modulators
03/11/2010US20100063075 Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives
03/11/2010US20100063067 Cyclic derivatives as modulators of chemokine receptor activity
03/11/2010US20100063043 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1, 3-oxazolines and their use as anticoagulant and antithrombotics
03/11/2010US20100063009 Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1.3-diol and an NSAID
03/11/2010US20100063001 Microbial-derived chondroitin sulfate
03/11/2010US20100062976 Synthesis of Cyclosporin Analogs
03/11/2010US20100062064 Method for Delivering A Pharmaceutical Composition to Patient in Need Thereof
03/11/2010US20100062055 Lipid-based nitric oxide donors
03/11/2010CA2736117A1 Compounds, compositions and methods of using same for modulating uric acid levels
03/11/2010CA2735806A1 Aminotriazolopyridines and their use as kinase inhibitors
03/11/2010CA2735709A1 Agent for treating myelofibrosis
03/11/2010CA2734500A1 Compounds that modulate intracellular calcium
03/10/2010EP2161280A2 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
03/10/2010EP2160470A2 Chimeric pufa polyketide synthase systems and uses thereof
03/10/2010CN101664388A transnasal transport/immunisation with highly adaptable carriers
03/10/2010CN100593401C Combination of an aromatase inhibitor with a bisphosphonate
03/09/2010US7674830 Reducing blood glucose concentrations, weight loss, and treating diseases and conditions mediated by the cyclooxygenase-2 and 5-lipoxygenase enzymes; an enzyme inhibitors
03/09/2010US7674809 Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
03/09/2010US7674777 Immunostimulatory nucleic acid molecules
03/09/2010US7674775 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants
03/09/2010US7674604 Using computer modeling to identify positions where cysteinal insertion will lock protein comprising integrin domain sequences into preferential configuration; directed protein evolution
03/09/2010CA2424346C Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome
03/09/2010CA2399813C Indol-3-yl derivatives
03/09/2010CA2379282C Amido spiropiperidines promote the release of growth hormone
03/09/2010CA2306313C Dipeptide nitriles
03/04/2010WO2010025436A2 Nitrogen and sulfur-containing heterocycle derivatives
03/04/2010WO2010025295A2 Compounds that modulate intracellular calcium
03/04/2010WO2010025267A2 Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
03/04/2010WO2010025135A2 Trimeprazine and ethopropazine derivatives for promoting bone growth
03/04/2010WO2010024549A2 Bone filler containing a sustained-release therapeutic agent for osteoporosis
03/04/2010WO2010024405A1 Ifn type-1 production inhibitor and method for searching for same
03/04/2010WO2010024258A1 Ring-fused azole derivative having pi3k-inhibiting activity
03/04/2010WO2010024226A1 Prophylactic or therapeutic agent for bone/joint diseases comprising, as active ingredient, pyrrole derivative having ureide group, aminocarbonyl group and substituted phenyl group as substituents
03/04/2010WO2010023463A2 Polymer blends
03/04/2010WO2010022737A1 Anti-cd5 antibodies
03/04/2010WO2010022581A1 Medical composition for treating hyperuricemia and the use thereof
03/04/2010WO2010022580A1 Medical composition for treating hyperuricemia and the use thereof
03/04/2010WO2010009068A3 Cyclohexenyl modulators of chemokine receptor activity
03/04/2010WO2009150118A3 Novel salts of (4-{[(5-{[(3-chlorophenyl)methyl]oxy}-2-methylphenyl)carbonyl]amino}-3-methylphenyl)acetic acid
03/04/2010WO2009148874A3 Gamma-lactam compounds for promoting bone growth
03/04/2010WO2009148620A3 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
03/04/2010WO2009010478A3 Use of piperidine derivatives as agonists of chemokine receptor activity
03/04/2010US20100056634 Novel compositions
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 820